Roche/Genentech was recognized with the ACRP-Avoca Sponsor Quality Award yesterday during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2019 annual conference.
The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event.
The following ACRP-Avoca Sponsor Quality Awards were announced:
- First Place – Roche/Genentech
- Second Place – Merck & Co.
- Third Place – AstraZeneca
Finalists for the ACRP-Avoca Quality Awards were chosen by investigational sites through a research study conducted by The Avoca Group over an eight-week period in early 2019.
In this research, investigational sites were asked to rate sponsor attributes aligned to quality outcomes. Specifically, functional attributes that support quality into design, execution, and oversight of clinical trials, as well as soft-skill areas such as communication and partnership.
“We congratulate all the finalists for having proven their ability to work effectively with investigate sites. This includes their ability to appreciate site operations, manage relationships, and ensure high-quality CRA support,” says Jim Kremidas, ACRP Executive Director. “Recognition of quality partners in the clinical trial community greatly supports our mission to promote excellence in clinical research.”
“Organizations that provide high quality support to investigative sites deserve to be recognized for their efforts,” says Patricia Leuchten, CEO of The Avoca Group. “It is an honor to partner with ACRP on the annual Quality Award to recognize the importance of ongoing collaboration among sites, sponsors, and CROs which benefits all companies and individuals who are responsible for the execution of clinical trials.”